Search
for
Sort by
Research 30 of 67
- Mitoxantrone
- Mitoxantrone
- Mitoxantrone, Etoposide and Prednisolone—a Novel Combination in The Treatment of Relapsed and Refractory Lymphoma
- [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer].
- Doxetaxel: new indication. Prostate cancer: a few more weeks.
- Cytostatics and immunosuppressive drugs
- Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Hypertensive crisis associated with St. John’s Wort
- Clinical Development of Topoisomerase-Interactive Drugs
- Efluvio anágeno. Hallazgos tricoscópicos
- Supplements That May Counteract Side Effects from Conventional Cancer Therapies
- Use of chemotherapy during human pregnancy
- Mucocutaneous reactions to chemotherapy
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Drug Reactions Affecting Hair: Diagnosis
- Drug-Induced Hair Disorders
- Redefining hormone resistance in prostate cancer
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Alopecia in Association with Malignancy: A Review
- An Update on Drug-Induced Pigmentation
- Medical Treatment of Hepatocellular Carcinoma: Any Progress?
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Biomaterials and Stem Cells: Promising Tools in Tissue Engineering and Biomedical Applications
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Dermatologic Adverse Events from Cancer Treatments
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Chemotherapy-Induced Alopecia